Literature DB >> 15567934

A case of granulocytic sarcoma during complete remission of acute myeloid leukemia with multiple masses involving the larynx and nasopharynx.

Tülay Ozçelik1, Ridvan Ali, Fahir Ozkalemkaş, Vildan Ozkocaman, Hakan Coşkun, Levent Erişen, Gülaydan Filiz.   

Abstract

A thirty-seven-year-old male patient presented with dysphagia and hoarseness six months after complete remission of acute myeloid leukemia (AML-M0), which had been treated with chemotherapy. Physical examination revealed left vocal cord paralysis and involvement of the 9th, 10th, and 12th cranial nerves. Sagittal and axial magnetic resonance scans of the nasopharynx and neck showed a mass in the left retropharyngeal and perivertebral regions, 6x4 cm in size; another mass in the left vallecula, and infiltration of the right preepiglottic tissue by another mass of 2 cm. There was no bone marrow involvement. A diagnosis of granulocytic sarcoma without leukemia relapse was made and the FLAG-Ida regimen was administered, after which partial regression of the masses was observed. However, the patient died due to a pulmonary infection on the 17th day of chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15567934

Source DB:  PubMed          Journal:  Kulak Burun Bogaz Ihtis Derg        ISSN: 1300-7475


  3 in total

1.  Newly diagnosed acute myeloid leukemia with neck swelling.

Authors:  Maha Al-Yahyai; Sulayma Al-Lamki; Muhanna Al-Musalhi
Journal:  Sultan Qaboos Univ Med J       Date:  2011-10-25

2.  Immunohistochemical patterns in the differential diagnosis of rhinopharyngeal granulocytic sarcoma.

Authors:  Elena Cantone; Michele Cavaliere; Antonella Miriam Di Lullo; Elia Guadagno; Maurizio Iengo
Journal:  Oncol Lett       Date:  2016-08-16       Impact factor: 2.967

3.  Isolated granulocytic sarcoma of the nasopharynx: a case report and review of the literature.

Authors:  Prakash Vishnu; Ravindra Reddy Chuda; Dick G Hwang; David M Aboulafia
Journal:  Int Med Case Rep J       Date:  2013-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.